Akers Biosciences Inc (NASDAQ:AKER)’s share price rose 8.7% during trading on Friday . The stock traded as high as $0.52 and last traded at $0.50, approximately 612,200 shares changed hands during trading. An increase of 126% from the average daily volume of 270,757 shares. The stock had previously closed at $0.46.
The company has a 50-day moving average of $0.44 and a 200 day moving average of $0.66.
A hedge fund recently raised its stake in Akers Biosciences stock. Candriam Luxembourg S.C.A. increased its stake in shares of Akers Biosciences Inc (NASDAQ:AKER) by 19.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 388,220 shares of the medical instruments supplier’s stock after buying an additional 63,221 shares during the quarter. Candriam Luxembourg S.C.A. owned 3.11% of Akers Biosciences worth $377,000 at the end of the most recent reporting period. Institutional investors own 9.25% of the company’s stock.
About Akers Biosciences (NASDAQ:AKER)
Akers Biosciences, Inc, together with its subsidiaries, develops, manufactures, and supplies rapid screening and testing products designed to deliver healthcare information to healthcare providers and consumers in the United States, the People's Republic of China, and internationally. The company's marketed products include BreathScan, a disposable breath alcohol detector; BreathScan PRO, a quantitative breath alcohol detection system; METRON, a disposable breath ketone device to monitor ketosis; and BreathScan Lync, a non-invasive, quantitative measurement of biological markers for health and wellness.
Featured Article: 12b-1 Fees
Receive News & Ratings for Akers Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akers Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.